CN101296690A - 具有延迟释放然后缓释的肠溶性质的液体剂型 - Google Patents

具有延迟释放然后缓释的肠溶性质的液体剂型 Download PDF

Info

Publication number
CN101296690A
CN101296690A CNA2006800396750A CN200680039675A CN101296690A CN 101296690 A CN101296690 A CN 101296690A CN A2006800396750 A CNA2006800396750 A CN A2006800396750A CN 200680039675 A CN200680039675 A CN 200680039675A CN 101296690 A CN101296690 A CN 101296690A
Authority
CN
China
Prior art keywords
dosage form
weight
active substance
concentration
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2006800396750A
Other languages
English (en)
Chinese (zh)
Inventor
袁静华
N·M·克利普斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eastman Chemical Co
Original Assignee
Eastman Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eastman Chemical Co filed Critical Eastman Chemical Co
Publication of CN101296690A publication Critical patent/CN101296690A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CNA2006800396750A 2005-10-24 2006-10-11 具有延迟释放然后缓释的肠溶性质的液体剂型 Pending CN101296690A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/257,432 US20070092559A1 (en) 2005-10-24 2005-10-24 Liquid dosage forms having enteric properties of delayed and then sustained release
US11/257,432 2005-10-24

Publications (1)

Publication Number Publication Date
CN101296690A true CN101296690A (zh) 2008-10-29

Family

ID=37744211

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2006800396750A Pending CN101296690A (zh) 2005-10-24 2006-10-11 具有延迟释放然后缓释的肠溶性质的液体剂型

Country Status (5)

Country Link
US (1) US20070092559A1 (enExample)
EP (1) EP1940365A2 (enExample)
JP (1) JP2009512699A (enExample)
CN (1) CN101296690A (enExample)
WO (1) WO2007050294A2 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
CA2597740C (en) 2006-04-26 2012-10-16 Supernus Pharmaceuticals, Inc. Modified-release preparations containing oxcarbazepine and derivatives thereof
US20100099696A1 (en) * 2008-10-16 2010-04-22 Anthony Edward Soscia Tamper resistant oral dosage forms containing an embolizing agent
EP2440210A4 (en) 2009-06-12 2014-01-29 Meritage Pharma Inc METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
GB2477590A (en) * 2010-02-05 2011-08-10 Biocopea Ltd A non-steroidal anti-inflammatory drug (NSAID) formulation comprising a lipid carrier
US9744132B2 (en) 2010-10-29 2017-08-29 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US9504664B2 (en) 2010-10-29 2016-11-29 Infirst Healthcare Limited Compositions and methods for treating severe pain
US9737500B2 (en) 2010-10-29 2017-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US9308213B2 (en) 2010-10-29 2016-04-12 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US8895536B2 (en) 2010-10-29 2014-11-25 Infirst Healthcare Ltd. Compositions and methods for treating chronic inflammation and inflammatory diseases
US10695431B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US9271950B2 (en) 2010-10-29 2016-03-01 Infirst Healthcare Limited Compositions for treating chronic inflammation and inflammatory diseases
US11202831B2 (en) 2010-10-29 2021-12-21 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US11224659B2 (en) 2010-10-29 2022-01-18 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US11730709B2 (en) 2010-10-29 2023-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US10695432B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in severe pain
AR101476A1 (es) 2014-08-07 2016-12-21 Acerta Pharma Bv Métodos para tratar cánceres, enfermedades inmunes y autoinmunes, y enfermedades inflamatorias en base a la tasa de ocupación de la tirosin quinasa de bruton (btk) y a la tasa de resíntesis de la tirosin quinasa de bruton (btk)
CN110314152B (zh) * 2018-11-27 2021-03-26 西安圣雪沙药物开发有限公司 一种布洛芬缓释微丸胶囊及其制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL148500B (nl) * 1967-10-07 1976-02-16 Scherer Gmbh R P Depotgeneesmiddelen in capsulevorm.
GB1322306A (en) * 1971-04-15 1973-07-04 Meiji Seika Co Stabilized antibiotic preparation and manufacturing process therefor
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
DE3500103C2 (de) * 1985-01-04 1987-01-22 R.P. Scherer GmbH, 6930 Eberbach Pharmazeutische Zubereitung mit einem in Wasser und Verdauungssäften schwer löslichen Wirkstoff
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
US4835186A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
JPS649932A (en) * 1987-07-01 1989-01-13 Toyo Capsel Kk Soft capsule preparation using newly combined component as the base
JPH082781B2 (ja) * 1988-10-18 1996-01-17 嘉明 川島 中空顆粒状医薬及びその製法
US5527545A (en) * 1989-09-18 1996-06-18 Recordati S.A. Chemical And Pharmaceutical Company Liquid-suspension controlled-release pharmaceutical composition
IT1250654B (it) * 1991-07-08 1995-04-21 Farcon Ag Metodo per la preparazione di forme farmaceutiche orali a rilascio prolungato contenenti sostanze attive a solubilita' dipendente dal valore di ph.
US5723151A (en) * 1995-11-06 1998-03-03 Eastman Chemical Company Cellulose acetate phthalate enteric coating compositions
EP0869810B1 (en) * 1996-06-19 2004-10-06 Novartis AG Cyclosporin-containing soft capsule preparations
US6120803A (en) * 1997-08-11 2000-09-19 Alza Corporation Prolonged release active agent dosage form adapted for gastric retention
US6191162B1 (en) * 1998-05-28 2001-02-20 Medical Research Institute Method of reducing serum glucose levels
US6312713B1 (en) * 1998-06-12 2001-11-06 Bernard Korol Polymer matrices for storage and sustained release of drugs and chemicals
US6139875A (en) * 1998-09-29 2000-10-31 Eastman Chemical Company Aqueous enteric coating composition and low gastric permeability enteric coating
US6174873B1 (en) * 1998-11-04 2001-01-16 Supergen, Inc. Oral administration of adenosine analogs
MXPA01006108A (es) * 1998-12-17 2002-09-18 Alza Corp Conversion de capsulas de gelatina rellenas de liquido en sistemas de liberacion controlada mediante multiples recubrimientos.
US6342249B1 (en) * 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
US6635281B2 (en) * 1998-12-23 2003-10-21 Alza Corporation Gastric retaining oral liquid dosage form
US6797283B1 (en) * 1998-12-23 2004-09-28 Alza Corporation Gastric retention dosage form having multiple layers
JP4610687B2 (ja) * 1999-11-15 2011-01-12 コニカミノルタホールディングス株式会社 原稿読み取り装置
US20040028744A1 (en) * 2002-06-17 2004-02-12 Sauwaluxana Tongaree Mucoadhesive composition
EP1713454A4 (en) * 2003-09-11 2008-07-02 Glykon Technologies Group Llc Enteric release of (-) - hydroxycitric acid
GB0403808D0 (en) * 2004-02-20 2004-03-24 Bioprogress Technology Ltd Films for use as dosage forms

Also Published As

Publication number Publication date
WO2007050294A2 (en) 2007-05-03
WO2007050294A3 (en) 2007-07-12
EP1940365A2 (en) 2008-07-09
JP2009512699A (ja) 2009-03-26
US20070092559A1 (en) 2007-04-26

Similar Documents

Publication Publication Date Title
CN101296690A (zh) 具有延迟释放然后缓释的肠溶性质的液体剂型
US10434139B2 (en) Oral pharmaceutical composition
RU2492854C2 (ru) Производство быстрорастворимых/распадающихся пленок, содержащих большое количество активных веществ
JPH11505253A (ja) 結腸デリバリー用の医薬投与形態
CN101084884B (zh) 一种可掩盖药物不良气味的口服膜剂组合物及其制备方法
JP2004512296A (ja) メチルフェニデート改変放出製剤
CZ20021536A3 (cs) Prostředek pro léčbu zácpy a syndromu dráždivého tračníku
AU2016344402A1 (en) Extended release film-coated capsules
EP0425699A1 (en) Oral preparation which can be released at suitable region in intestine
Kotagale et al. Eudragit-S, Eudragit-L and cellulose acetate phthalate coated polysaccharide tablets for colonic targeted delivery of azathioprine
CN106572980A (zh) 包含他喷他多的防篡改即释胶囊制剂
EP2709599A1 (en) Pharmaceutical composition comprising drotaverine
KR20000053326A (ko) 결장내 운반에 사용되는 다층 장용성 중합체 코팅물을 갖는 약제학적 제형
US20160000734A1 (en) Method and compositions of civamide to treat disease of the intestines
US20060240051A1 (en) Eutectic blends containing a water soluble vitamin derivative
CN104906047B (zh) 一种普伐他汀钠长效缓释微球的制备方法
AU2015317469B2 (en) Pulsed release phenylephrine dosage forms
EP3796904A1 (en) Sustained release acemetacin compositions
CN106727407B (zh) 一种二甲双胍控释制剂及其制备方法
Hoshi et al. Creating PVA copolymer capsules
TW202412747A (zh) 經塗覆的腸溶軟膠囊
US20210113479A1 (en) Dosage forms for delivery of medicines to the lower gastrointestinal tract
BR112020008756A2 (pt) composições farmacêuticas orais de lorazepam resistentes a álcool
EP3595641A1 (en) Method for relieving sinus congestion

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20081029